EClinical Medicine: Clinical differences between neo-crown pneumonia and other respiratory diseases.

Most of the current clinical performance, diagnosis and results data for Covid-19 patients are summarized from the case itself, and comparative studies with other patients with acute respiratory diseases are inadequate.
researchers recently collected data on patients with acute respiratory diseases received in emergency departments between February 3 and March 31, 2020, and patients were tested for neo-coronavirus nucleic acid, comparing differences in clinical performance, diagnosis, treatment and results between patients with neo-coronary pneumonia and patients with non-neo-coronary pneumonia.
a total of 316 patients participated in the study, of which 33 tested positive for neo-coronavirus and 31 tested positive for other respiratory viruses, with no co-infection of new coronavirus with other respiratory viruses.
longer (7 days vs 3 days) of symptoms in patients who tested negative for the virus than those who tested negative for the virus.
hospitalization rate was higher (79% vs 56%) and longer hospital stays (10.7 vs 4.7 days) for patients with neo-crown pneumonia, the risk of developing ARDS was higher (23% vs 3%).
covid-19 infection was not associated with most co-diseases, medications, symptoms, vital signs, laboratory results, treatments, and outcomes.
patients with neo-coronary pneumonia are at higher risk of hospitalization, length of stay, and development of acute respiratory distress syndrome than other acute respiratory diseases.
.